PITTSBURGH, May 8, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced positive results of its Phase 3 study (NCT05139121) evaluating the contraceptive ...
Xulane (norelgestromin/ethinyl estradiol) is a prescription drug used to prevent pregnancy. It comes as a patch you wear on your skin. Xulane may be safe if used during early pregnancy, but it’s not ...
The Company expects to submit the New Drug Application for Xulane Lo in the second half of 2025. A low dose combination hormonal patch was found to be effective for pregnancy prevention based on ...
The multicenter, open-label, single-arm study, evaluated the contraceptive efficacy of investigational XULANE LO low dose patch when used over thirteen 28-day cycles in 1,272 healthy, post-menarcheal, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results